Biotalys NV (EBR:BTLS)

Market Cap	73.44M -54.5%
Revenue (ttm)	n/a
Net Income	-16.77M
EPS	-0.44
Shares Out	45.44M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	14,080
Open	1.638
Previous Close	1.620
Day's Range	1.580 - 1.638
52-Week Range	1.560 - 5.280
Beta	1.42
Analysts	Buy
Price Target	4.70 (+190.84%)
Earnings Date	Mar 18, 2027

About Biotalys NV

Biotalys NV, an agricultural technology company, discovers and develops protein-based biocontrol solutions in Belgium and internationally. The company offers biofungicides and bioinsecticides. It also provides the AGROBODY Foundry technology platform, which generates protein-based crop protection products. In addition, the company develops EVOCA 1st generation, EVOCA Next generation, and BIOFUN-6 targeting botrytis, powdery mildew, and other fungi in fruits and vegetables; BIOFUN-7 targeting leafspot disease in cowpeas and other legumes; BIOFUN...

• Industry: Agricultural Inputs
• Sector: Materials
• Founded: 2013
• Employees: 38
• Stock Exchange: Euronext Brussels
• Ticker Symbol: BTLS

Analyst Summary

According to 2 analysts, the average rating for BTLS stock is "Buy." The 12-month stock price target is €4.70, which is an increase of 190.84% from the latest price.

Price Target

€4.70

(190.84% upside)

Analyst Consensus: Buy

Data Sources: S&P Global Market Intelligence and Financial Modeling Prep

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep.

Last checked:

Oct 30, 2026

Data Sources Report a data error